A Phase II Study to Investigate the Efficacy and Safety of Two Different Doses of Twice Daily Distal Jejunal-release Dextrose Beads Formulations (APHD 012 and APHD 002) Combined With a Gel Composition, Compared With Two Different Doses of the Placebo Beads Formulations (APHP 012 and APHP 002) Combined With a Gel Composition in Obese Subjects With Weight Related Comorbidities
Latest Information Update: 14 Jun 2025
At a glance
- Drugs APHD-012 (Primary)
- Indications Obesity
- Focus Therapeutic Use
- Sponsors Aphaia Pharma
Most Recent Events
- 14 Jun 2025 New trial record